Abstract:Background: Acute myeloid leukemia (AML) is an aggressive hematopoietic malignancy. Transient receptor potential (TRP) channels in AML still need to be further explored. A TRP channel-related model based on machine learning was established in this study. Methods: The data were downloaded from TCGA-LAML and Genome-Tissue Expression (GTEx). TRP-related genes (TRGs) were extracted from previous literature. With the use of Single-Sample Gene Set Enrichment Analysis (ssGSEA), TRP enrichment scores (TESs) were calculated. The limma package was used to identify differentially expressed genes (DEGs), and univariate Cox regression analysis was performed to identify prognostic DEGs. The above prognostic DEGs were analyzed by Random Survival Forest and least absolute shrinkage and selection operator (Lasso) analysis to create the TRP signature. The Kaplan-Meier and receiver operating characteristic (ROC) curves were plotted to investigate the efficiency and accuracy of prognostic prediction. Moreover, genomic mutation analysis was based on GISTIC analysis. Based on ESTIMATE, TIMER, MCPcounter, and ssGSEA, the tumor microenvironment and immunological characteristics were expressly evaluated to explore immunotherapeutic strategies. Enrichment analysis for TRP signature was based on the Kyoto Encyclopedia of Genes Genomes (KEGG), Gene Ontology (GO), over-representation analysis (ORA), and Gene Set Enrichment Analysis (GSEA). Genomics of Drug Sensitivity in Cancer (GDSC) and pRRophetic were used to carry out drug sensitivity analysis. Conclusively, SCHIP1 was randomly selected to perform in vitro cyto-functional experiments. Results: The worse clinical outcomes of patients with higher TESs were observed. There were 107 differentially expressed TRGs identified. Our data revealed 57 prognostic TRGs. Eight TRGs were obtained to establish the prognostic TRP signature, and the worse clinical outcomes of patients with higher TRP scores were found. The efficiency and accuracy of TRP signature in predicting prognosis were confirmed by ROC curves and five external validation datasets. Our data revealed that the mutation rates of DNMT3A, IDH2, MUC16, and TTN were relatively high. The level of infiltrating immune cell populations, stromal, immune, and ESTIMATE scores increased as the TRP scores increased. Nevertheless, AML patients with lower TRP scores exhibited more tumor purity. The TRP scores were found to be correlated with immunomodulators and immune checkpoints, thus revealing immune characteristics and immunotherapeutic strategies. The IC50 values of six chemotherapeutics were lower in the high TRP score (HTS) group. Finally, it was found that SCHIP1 may be the oncogenic gene. Conclusion: The results of this study will help in understanding the role of TRP and SCHIP1 in the prognosis and development of AML.

Tumor Necrosis Factor Receptor Type 1-Associated Death Domain Protein is a Potential Prognostic Biomarker in Acute Myeloid Leukemia.

Expression and Clinical Significance of ID1 Gene in Acute Myeloid Leukemia

Expression and Clinical Significance of Phospholipase D1 in De Novo Acute Myeloid Leukemia

The Classical Apoptotic Adaptor FADD Regulates Glycolytic Capacity in Acute Lymphoblastic Leukemia

Clinical significance of CD34<SUP>+</SUP>CD117<SUP>dim</SUP>/CD34<SUP>+</SUP>CD117<SUP>bri</SUP> myeloblast-associated gene expression in t(8;21) acute myeloid leukemia

Clinical significance of CD34 + CD117 dim /CD34 + CD117 bri myeloblast-associated gene expression in t(8;21) acute myeloid leukemia

Integration of CD34 + CD117 Dim Population Signature Improves the Prognosis Prediction of Acute Myeloid Leukemia

Machine learning-based biomarker screening for acute myeloid leukemia prognosis and therapy from diverse cell-death patterns

Studying Signaling Pathway Activation in TRAIL-Resistant Macrophage-Like Acute Myeloid Leukemia Cells

Upregulated FADD is associated with poor prognosis, immune exhaustion, tumor malignancy, and immunotherapy resistance in patients with lung adenocarcinoma

Relationship between TRX1 and JAB1 in acute myelogenous leukemia

MT1E in AML: a gateway to understanding regulatory cell death and immunotherapeutic responses

Clinical Significance and Potential Function of Complement Factor D in Acute Myeloid Leukemia

The profile and prognostic significance of bone marrow T-cell differentiation subsets in adult AML at diagnosis

A Novel Identified Necroptosis-Related Risk Signature for Prognosis Prediction and Immune Infiltration Indication in Acute Myeloid Leukemia Patients

High Aldehyde Dehydrogenase Activity at Diagnosis Predicts Relapse in Patients with T(8;21) Acute Myeloid Leukemia

High trophinin-associated protein expression predicts good survival in acute myeloid leukemia with normal cytogenetics

Identification of TMEM217 As a Novel Prognostic Biomarker and Potential Therapeutic Target in Acute Myeloid Leukemia

Comprehensive bioinformatic analysis of the expression and prognostic significance of TSC22D domain family genes in adult acute myeloid leukemia

A transient receptor potential channel-related model based on machine learning for evaluating tumor microenvironment and immunotherapeutic strategies in acute myeloid leukemia

High Expression of CLEC11A Predicts Favorable Prognosis in Acute Myeloid Leukemia